Results 1 to 10 of about 1,452 (117)

Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotype [PDF]

Scientific Reports
Brolucizumab is a second-generation vascular endothelial growth factor (VEGF) inhibitor. To date, there have been no reports comparing treatment outcomes between exudative age-related macular degeneration with or without the pachychoroid phenotype using ...
Yoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, Wataru Kikushima, Kenji Kashiwagi   +4 more
doaj   +2 more sources

Natural Course of Pachychoroid Pigment Epitheliopathy

Ophthalmology Science, 2022
Purpose: To investigate the natural course of pachychoroid pigment epitheliopathy (PPE). Design: A retrospective cohort study. Subjects: From the Kyoto central serous chorioretinopathy (CSC) cohort consisting of 548 patients with CSC as of September 2020,
Mariko Yagi, Masahiro Miyake, Yoshikatsu Hosoda   +2 more
exaly   +3 more sources

Clinical Characteristics and Progression of Pachychoroid and Conventional Geographic Atrophy

Ophthalmology Science
Purpose: To elucidate the clinical characteristics and progression rates of pachychoroid and conventional geographic atrophy (GA). Design: Retrospective, multicenter, observational study.
Moeko Kawai, Yukiko Sato, Ayako Takahashi   +2 more
exaly   +3 more sources

Retinitis pigmentosa with acute central serous chorioretinopathy with pachychoroid phenotype

Indian Journal of Ophthalmology. Case Reports, 2023
We report a case of retinitis pigmentosa (RP) coexisting with acute central serous chorioretinopathy (CSCR) with pachychoroid phenotype. A 37-year-old male showed clinical features of RP in both eyes with acute CSCR in the right eye.
Nikita Goel, Ahana Sen, Surabhi Chattree, Saurabh Kumar, Rupak Roy   +4 more
doaj   +1 more source

Pachychoroid Spectrum Disorders: An Updated Review

Journal of Ophthalmic & Vision Research, 2023
Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment ...
Richard B. Brown, Sashwanthi Mohan, Jay Chhablani   +2 more
doaj   +1 more source

Active concurrent central serous chorioretinopathy and pachychoroid neovasculopathy managed with combination therapy of photodynamic therapy and anti-vascular endothelial growth factor agent

Indian Journal of Ophthalmology. Case Reports, 2021
Pachychoroid disease spectrum includes central serous chorioretinopathy (CSR) and pachychoroid neovasculopathy (PNV). Pachychoroid phenotype is characterized by choroidal hyperpermeability, dilated choroidal vessels (pachyvessels), and focal or diffuse ...
Barun Garg, Isha Gupta, Sugandha Goel, Deepak Senger, Kumar Saurabh, Rupak Roy   +5 more
doaj   +1 more source

Choroidal congestion mouse model: Could it serve as a pachychoroid model?

PLoS ONE, 2021
Pachychoroid spectrum diseases have been described as a new clinical entity within the spectrum of macular disorders. "Pachychoroid" is defined as choroidal thickening associated with dilated outer choroidal vessels often showing retinal pigment ...
Hidetaka Matsumoto, Ryo Mukai, Junki Hoshino, Mai Oda, Toshiyuki Matsuzaki, Yasuki Ishizaki, Koji Shibasaki, Hideo Akiyama   +7 more
doaj   +1 more source

Focal Choroidal Excavation: Epidemiology, Clinical Characteristics and Multimodal Imaging Findings

Diagnostics, 2023
Background: Focal choroidal excavation (FCE) is one of the pachychoroid spectrum diseases. It may be an isolated lesion or associated with other ophthalmological disorders.
Paulina Szabelska, Justyna Mędrzycka, Joanna Brydak-Godowska, Radosław Różycki, Joanna Gołębiewska   +4 more
doaj   +1 more source

Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease

Scientific Reports, 2020
The aim of this study was to explore the relative prevalence and clinical differences between age-related macular degeneration (AMD) and pachychoroid disease in patients older than 50 years with newly diagnosed exudative neovascular maculopathy, and also
Enrico Borrelli, Marco Battista, Francesco Gelormini, Riccardo Sacconi, Lea Querques, Giovanna Vella, Chiara Viganò, Francesco Bandello, Giuseppe Querques   +8 more
doaj   +1 more source

Clinical characteristics and pachychoroid incidence in Japanese patients with neovascular age-related macular degeneration

Scientific Reports, 2022
The phenotypes of neovascular age-related macular degeneration (nAMD) are recognized as differing between Caucasian and Asian patients. Pachychoroid is thought to be more prevalent in Asians than in Caucasians, and may be involved in the development of ...
Hidetaka Matsumoto, Junki Hoshino, Ryo Mukai, Kosuke Nakamura, Shoji Kishi, Hideo Akiyama   +5 more
doaj   +1 more source